Becton, Dickinson and Company

BDX Healthcare Medical Instruments & Supplies

Becton, Dickinson and Company’s revenue for fiscal 2025 (year ended September 2025) was $21.8 billion, up 8.24% from fiscal 2024.

Revenue
−9.55%
EPS
−31.5%
Free cash flow
−31.6%
Total debt
−22.9%

Quarter to June 2026, against a year earlier

212.28 1.27 −0.59%
Market cap
$58.2B
P/E
64.1×
Fwd P/E
39.2×
Dividend yield
1.87%
F-score
7/9
Altman Z
1.85
Beneish M
−2.64
Dividend safety
67/100

Becton, Dickinson and Company (BDX) Operating cash flow

Alert me on Operating cash flow

Becton, Dickinson and Company's operating cash flow for fiscal 2025 was $3.4B, down 10.8% from $3.8B in fiscal 2024. Over the twelve months to 30 June 2026 it was $4.0B. Over the past ten years it has ranged from $1.7B (fiscal 2015) to $4.1B (fiscal 2021); the current reading is higher than 82% of that period. Becton, Dickinson and Company ranks 2nd of 51 Medical Instruments & Supplies companies by operating cash flow.

Operating cash flow, annual

Embed this chart

Annual newest first

Period Operating cash flow Change
FY2025 $3.4B (10.77%)
FY2024 $3.8B 28.56%
FY2023 $3.0B 21.00%
FY2022 $2.5B (40.11%)
FY2021 $4.1B 40.48%
FY2020 $2.9B (11.80%)
FY2019 $3.3B 16.23%
FY2018 $2.9B 12.35%
FY2017 $2.6B (0.35%)
FY2016 $2.6B 47.92%

Quarterly newest first

Period Operating cash flow Change
Jun 2026 $776.0M 15.65%
Mar 2026 $671.0M 2.13%
Dec 2025 $657.0M (64.52%)
Sep 2025 $1.9B 70.06%
42 more quarters

Against its own ten years

Low $1.7B High $4.1B
Ten-year median $2.9B
Current reading's percentile 82

Operating cash flow against peers

What Operating cash flow is

Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.

Reported line item

The full definition of Operating cash flow →

More on BDX